Patent details
EP2132315 Title: REOVIRUSES HAVING MODIFIED SEQUENCES
Basic Information
- Publication number:
- EP2132315
- PCT Application Number:
- PCT/CA/2008/000483
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP087335873
- PCT Publication Number:
- WO/2008/110004
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- REOVIRUSES HAVING MODIFIED SEQUENCES
- French Title of Invention:
- REOVIRUS AYANT DES SEQUENCES MODIFIEES
- German Title of Invention:
- REOVIREN MIT MODIFIZIERTEN SEQUENZEN
- SPC Number:
Dates
- Filing date:
- 11/03/2008
- Grant date:
- 15/07/2015
- EP Publication Date:
- 15/07/2015
- PCT Publication Date:
- 18/09/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 16/12/2009
- EP B1 Publication Date:
- 15/07/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 11/03/2016
- Expiration date:
- 11/03/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 11/03/2008
- Name:
- Oncolytics Biotech Inc.
- Address:
- Suite 210 1167 Kensington Crescent N. W., Calgary, AB T2N 1X7, Canada (CA)
Inventor
- Name:
- COFFEY Matthew C.
- Address:
- Canada (CA)
Priority
1
- Priority Number:
- 894425 P
- Priority Date:
- 12/03/2007
- Priority Country:
- United States (US)
2
- Priority Number:
- 989568 P
- Priority Date:
- 21/11/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C12N 15/46;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|